Fisher Asset Management LLC increased its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 17.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,628 shares of the company’s stock after purchasing an additional 11,005 shares during the quarter. Fisher Asset Management LLC’s holdings in Colgate-Palmolive were worth $6,603,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Bank OZK lifted its position in shares of Colgate-Palmolive by 6.9% during the 4th quarter. Bank OZK now owns 2,270 shares of the company’s stock valued at $206,000 after acquiring an additional 147 shares during the last quarter. Maple Capital Management Inc. lifted its holdings in shares of Colgate-Palmolive by 3.7% during the fourth quarter. Maple Capital Management Inc. now owns 126,732 shares of the company’s stock valued at $11,521,000 after purchasing an additional 4,504 shares during the last quarter. SVB Wealth LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $2,782,000. Flputnam Investment Management Co. increased its stake in Colgate-Palmolive by 1.8% in the 4th quarter. Flputnam Investment Management Co. now owns 168,367 shares of the company’s stock worth $15,306,000 after purchasing an additional 3,047 shares in the last quarter. Finally, Parkside Financial Bank & Trust raised its holdings in Colgate-Palmolive by 3.0% during the 4th quarter. Parkside Financial Bank & Trust now owns 6,673 shares of the company’s stock worth $607,000 after buying an additional 194 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Stock Performance
CL opened at $91.09 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock’s 50 day moving average price is $88.73 and its two-hundred day moving average price is $95.29. The firm has a market capitalization of $73.92 billion, a P/E ratio of 25.88, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30.
Colgate-Palmolive Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.20%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is presently 56.82%.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on CL shares. Wells Fargo & Company dropped their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Stifel Nicolaus reduced their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Morgan Stanley decreased their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Finally, Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $101.61.
Read Our Latest Research Report on Colgate-Palmolive
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- How to Use the MarketBeat Excel Dividend Calculator
- GitLab: Get In While It’s Down—Big Rebound Ahead
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Tesla Stock: Finding a Bottom May Take Time
- Most active stocks: Dollar volume vs share volume
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.